vs
1 800 FLOWERS COM INC（FLWS）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是1 800 FLOWERS COM INC的1.1倍（$772.1M vs $702.2M），Revvity净利率更高（12.7% vs 10.0%，领先2.7%），Revvity同比增速更快（5.9% vs -9.5%），1 800 FLOWERS COM INC自由现金流更多（$302.2M vs $161.8M），过去两年Revvity的营收复合增速更高（9.0% vs -7.6%）
1 800 FLOWERS COM INC是美国知名的全渠道鲜花礼品零售企业，主营鲜花花束、礼品篮、美食礼盒、定制礼物及家居装饰品，服务北美地区个人及企业客户，覆盖节日、生日、纪念日等各类送礼场景。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
FLWS vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.1倍
$702.2M
营收增速更快
RVTY
高出15.3%
-9.5%
净利率更高
RVTY
高出2.7%
10.0%
自由现金流更多
FLWS
多$140.5M
$161.8M
两年增速更快
RVTY
近两年复合增速
-7.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $702.2M | $772.1M |
| 净利润 | $70.6M | $98.4M |
| 毛利率 | 42.1% | — |
| 营业利润率 | 10.6% | 14.5% |
| 净利率 | 10.0% | 12.7% |
| 营收同比 | -9.5% | 5.9% |
| 净利润同比 | 9.6% | 3.9% |
| 每股收益（稀释后） | $1.10 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLWSRVTY
| Q4 25 | $702.2M | $772.1M | ||
| Q3 25 | $215.2M | $698.9M | ||
| Q2 25 | $336.6M | $720.3M | ||
| Q1 25 | $331.5M | $664.8M | ||
| Q4 24 | $775.5M | $729.4M | ||
| Q3 24 | $242.1M | $684.0M | ||
| Q2 24 | — | $691.7M | ||
| Q1 24 | $379.4M | $649.9M |
净利润FLWSRVTY
| Q4 25 | $70.6M | $98.4M | ||
| Q3 25 | $-53.0M | $46.7M | ||
| Q2 25 | $-51.9M | $53.9M | ||
| Q1 25 | $-178.2M | $42.2M | ||
| Q4 24 | $64.3M | $94.6M | ||
| Q3 24 | $-34.2M | $94.4M | ||
| Q2 24 | — | $55.4M | ||
| Q1 24 | $-16.9M | $26.0M |
毛利率FLWSRVTY
| Q4 25 | 42.1% | — | ||
| Q3 25 | 35.7% | 53.6% | ||
| Q2 25 | 35.5% | 54.5% | ||
| Q1 25 | 31.7% | 56.5% | ||
| Q4 24 | 43.3% | — | ||
| Q3 24 | 38.1% | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | 36.6% | 54.6% |
营业利润率FLWSRVTY
| Q4 25 | 10.6% | 14.5% | ||
| Q3 25 | -23.5% | 11.7% | ||
| Q2 25 | -16.5% | 12.6% | ||
| Q1 25 | -58.4% | 10.9% | ||
| Q4 24 | 11.7% | 16.3% | ||
| Q3 24 | -19.4% | 14.3% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | -7.4% | 6.8% |
净利率FLWSRVTY
| Q4 25 | 10.0% | 12.7% | ||
| Q3 25 | -24.6% | 6.7% | ||
| Q2 25 | -15.4% | 7.5% | ||
| Q1 25 | -53.8% | 6.4% | ||
| Q4 24 | 8.3% | 13.0% | ||
| Q3 24 | -14.1% | 13.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | -4.5% | 4.0% |
每股收益（稀释后）FLWSRVTY
| Q4 25 | $1.10 | $0.86 | ||
| Q3 25 | $-0.83 | $0.40 | ||
| Q2 25 | $-0.80 | $0.46 | ||
| Q1 25 | $-2.80 | $0.35 | ||
| Q4 24 | $1.00 | $0.77 | ||
| Q3 24 | $-0.53 | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | $-0.26 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $193.3M | $919.9M |
| 总债务越低越好 | $123.5M | — |
| 股东权益账面价值 | $289.7M | $7.3B |
| 总资产 | $893.1M | $12.2B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资FLWSRVTY
| Q4 25 | $193.3M | $919.9M | ||
| Q3 25 | $7.7M | $931.4M | ||
| Q2 25 | $46.5M | $991.8M | ||
| Q1 25 | $84.7M | $1.1B | ||
| Q4 24 | $247.2M | $1.2B | ||
| Q3 24 | $8.4M | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $184.0M | $1.7B |
总债务FLWSRVTY
| Q4 25 | $123.5M | — | ||
| Q3 25 | $128.9M | — | ||
| Q2 25 | $134.8M | — | ||
| Q1 25 | $142.3M | — | ||
| Q4 24 | $157.5M | — | ||
| Q3 24 | $172.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $179.4M | — |
股东权益FLWSRVTY
| Q4 25 | $289.7M | $7.3B | ||
| Q3 25 | $217.5M | $7.4B | ||
| Q2 25 | $268.3M | $7.6B | ||
| Q1 25 | $317.7M | $7.6B | ||
| Q4 24 | $495.1M | $7.7B | ||
| Q3 24 | $433.4M | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | $485.3M | $7.8B |
总资产FLWSRVTY
| Q4 25 | $893.1M | $12.2B | ||
| Q3 25 | $840.5M | $12.1B | ||
| Q2 25 | $772.6M | $12.4B | ||
| Q1 25 | $806.2M | $12.4B | ||
| Q4 24 | $1.1B | $12.4B | ||
| Q3 24 | $1.0B | $12.8B | ||
| Q2 24 | — | $13.4B | ||
| Q1 24 | $1.0B | $13.4B |
负债/权益比FLWSRVTY
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $309.9M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $302.2M | $161.8M |
| 自由现金流率自由现金流/营收 | 43.0% | 21.0% |
| 资本支出强度资本支出/营收 | 1.1% | 2.6% |
| 现金转化率经营现金流/净利润 | 4.39× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-39.5M | $509.4M |
8季度趋势，按日历期对齐
经营现金流FLWSRVTY
| Q4 25 | $309.9M | $182.0M | ||
| Q3 25 | $-139.0M | $138.5M | ||
| Q2 25 | $-27.1M | $134.3M | ||
| Q1 25 | $-150.6M | $128.2M | ||
| Q4 24 | $328.5M | $174.2M | ||
| Q3 24 | $-177.2M | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | $-112.7M | $147.6M |
自由现金流FLWSRVTY
| Q4 25 | $302.2M | $161.8M | ||
| Q3 25 | $-145.6M | $120.0M | ||
| Q2 25 | $-36.1M | $115.5M | ||
| Q1 25 | $-160.0M | $112.2M | ||
| Q4 24 | $317.6M | $149.8M | ||
| Q3 24 | $-189.3M | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | $-121.4M | $129.7M |
自由现金流率FLWSRVTY
| Q4 25 | 43.0% | 21.0% | ||
| Q3 25 | -67.7% | 17.2% | ||
| Q2 25 | -10.7% | 16.0% | ||
| Q1 25 | -48.3% | 16.9% | ||
| Q4 24 | 41.0% | 20.5% | ||
| Q3 24 | -78.2% | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | -32.0% | 20.0% |
资本支出强度FLWSRVTY
| Q4 25 | 1.1% | 2.6% | ||
| Q3 25 | 3.1% | 2.6% | ||
| Q2 25 | 2.7% | 2.6% | ||
| Q1 25 | 2.8% | 2.4% | ||
| Q4 24 | 1.4% | 3.4% | ||
| Q3 24 | 5.0% | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | 2.3% | 2.7% |
现金转化率FLWSRVTY
| Q4 25 | 4.39× | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 5.11× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLWS
| Gourmet Foods And Gift Baskets | $499.0M | 71% |
| Ecommerce | $179.5M | 26% |
| Bloom Net | $22.1M | 3% |
| Other | $1.7M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
